High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation.
about
Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients.Genetics of ancestry-specific risk for relapse in acute lymphoblastic leukemiaA pre-clinical model of resistance to induction therapy in pediatric acute lymphoblastic leukemiaImproving the identification of high risk precursor B acute lymphoblastic leukemia patients with earlier quantification of minimal residual diseasePrognostic significance of minimal residual disease in high risk B-ALL: a report from Children's Oncology Group study AALL0232.Incidence and outcome of osteonecrosis in children and adolescents after intensive therapy for acute lymphoblastic leukemia (ALL).TFDP3 confers chemoresistance in minimal residual disease within childhood T-cell acute lymphoblastic leukemia.Risk factors for relapse in childhood acute lymphoblastic leukemia: prediction and prevention.Risk factors in patients undergoing haploidentical hematopoietic stem cell transplantation for high-risk childhood acute leukemia.Changes in body mass index in long-term survivors of childhood acute lymphoblastic leukemia treated without cranial radiation and with reduced glucocorticoid therapy.When Less Is Good, Is None Better? The Prognostic and Therapeutic Significance of Peri-Transplant Minimal Residual Disease Assessment in Pediatric Acute Lymphoblastic Leukemia.Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: an international collaborative study.Heterogeneity in mechanisms of emergent resistance in pediatric T-cell acute lymphoblastic leukemia.Acute Sensitivity of Ph-like Acute Lymphoblastic Leukemia to the SMAC-Mimetic Birinapant.Activity of the pan-class I phosphoinositide 3-kinase inhibitor NVP-BKM120 in T-cell acute lymphoblastic leukemia.High prevalence of relapse in children with Philadelphia-like acute lymphoblastic leukemia despite risk-adapted treatment.A risk score including microdeletions improves relapse prediction for standard and medium risk precursor B-cell acute lymphoblastic leukaemia in children.RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia.Bufalin Enhances Immune Responses in Leukemic Mice Through Enhancing Phagocytosis of Macrophage
P2860
Q33573735-2B43470C-4BA9-4E12-AB77-8F9E3927DED9Q33774499-2C2541E9-AA36-4FE3-8A88-A2A8D4CB0F5FQ34448969-9743F767-EEFB-49E0-9FA9-171B838EACEEQ35022780-517B66C5-D6B8-4C80-9F18-79C559B090F8Q35976588-C3498156-4B7E-477D-9ADF-C4444C560022Q36895136-B555E221-6018-42C4-A8BE-1C8B5967FD03Q37702104-D77205B2-F8BB-4A37-A5D3-EFFE003CE507Q38264774-E1C6BD47-FFF6-4F02-AD14-4E82D8BBB08FQ38616426-F2E6B80D-3127-4345-9DAB-0709B3BEF6C7Q39174561-5094BA18-AD80-4DE3-8255-C9AAA5BCF991Q39420711-8B1B01AF-FDFC-4032-ABA4-E5F11E372684Q41556401-7EC08C1A-0A4F-4261-8392-47FA8D0DCEC2Q41781135-1FBF091C-9F19-4C65-BB38-90BB921D7161Q42226188-B8D1460E-1534-445D-9621-90FB8F4C00F8Q44498168-EDE15AF7-CF81-4362-B290-6BC3679F7402Q47142310-2FEEDC89-4389-4F49-A29F-F0B49523C62EQ47203054-B067DEBF-BB92-4057-92BC-1618B52062CEQ47875530-B48B714B-ACED-4F7B-95CA-2C2CC07BD5E3Q58765911-7F6AD224-E45E-4E35-A606-58EE85A9F29D
P2860
High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
High-risk childhood acute lymp ...... nd allogeneic transplantation.
@en
High-risk childhood acute lymp ...... nd allogeneic transplantation.
@nl
type
label
High-risk childhood acute lymp ...... nd allogeneic transplantation.
@en
High-risk childhood acute lymp ...... nd allogeneic transplantation.
@nl
prefLabel
High-risk childhood acute lymp ...... nd allogeneic transplantation.
@en
High-risk childhood acute lymp ...... nd allogeneic transplantation.
@nl
P2093
P2860
P50
P356
P1433
P1476
High-risk childhood acute lymp ...... and allogeneic transplantation
@en
P2093
E S J M de Bont
E van der Schoot
G J L Kaspers
G M Marshall
H A de Groot-Kruseman
H van den Berg
L Dalla Pozza
P2860
P2888
P304
P356
10.1038/LEU.2013.44
P577
2013-02-14T00:00:00Z
P5875
P6179
1009486126